The role of Smads in BMP signaling

Frontiers in Bioscience

Volumn 8, Issue SUPPL., 2003, Pages

  Nishimura, Riko ^a   Hata, Kenji ^a   Ikeda, Fumiyo ^a   Matsubara, Takuma ^a   Yamashita, Kenji ^a   Ichida, Fumitaka ^a   Yoneda, Toshiyuki ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

BMP; Cytokine; Osteoblast; Review; Smad; TGF; TGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN; GROWTH FACTOR; HORMONE; PROTEIN P300; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; DNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN;

APOPTOSIS; BONE DEVELOPMENT; BONE METABOLISM; CELL DIFFERENTIATION; CELL NUCLEUS; CYTOPLASM; DNA BINDING; EMBRYO DEVELOPMENT; GENE EXPRESSION; HUMAN; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; PHYSIOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEINS; DNA-BINDING PROTEINS; HUMANS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANS-ACTIVATORS;

EID: 3142782299     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1049     Document Type: Review

References (82)

1. Massague J.: TGF-β signaling: receptors, transducers, and Mad proteins. Cell 85, 947-950 (1996)
2. Derynck R. & Y. Zhang: Intracellular signalling: the mad way to do it. Curr Biol 6, 1226-1229 (1996)
3. Heldin C.H., K. Miyazono & P. ten Dijke: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471 (1997)
4. Wrana J.L.: Regulation of Smad activity. Cell 100, 189-192 (2000)
5. Massague J. & D. Wotton: Transcriptional control by the TGF-β/Smad signaling system. EMBO J 19, 1745-1754 (2000)
6. Tsukazaki T., T.A. Chiang, A.F. Davison, L. Attisano & J.L. Wrana: SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell 95, 779-791 (1998)
7. Howell M., F. Itoh, C.E. Pierreux, S. Valgeirsdottir, S. Itoh, P. ten Dijke & C.S. Hill: Xenopus Smad4β is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes. Dev Biol 214, 354-369 (1999)
8. Chen Y.G., A. Hata, R.S. Lo, D. Wotton, Y. Shi, N. Pavletich & J. Massague: Determinants of specificity in TGF-β signal transduction. Genes Dev 12, 2144-2152 (1998)
9. Imamura T., M. Takase, A. Nishihara, E. Oeda, J. Hanai, M. Kawabata & K. Miyazono: Smad6 inhibits signalling by the TGF-β superfamily. Nature 389, 622-626 (1997)
10. Nakao A., M. Afrakhte, A. Moren, T. Nakayama, J.L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N.E. Heldin, C.H. Heldin & P. ten Dijke: Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 389, 631-635 (1997)
11. Hata A., G. Lagna, J. Massague & A. Hemmati-Brivanlou: Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12, 186-197 (1998)
12. Takase M., T. Imamura, T.K. Sampath, K. Takeda, H. Ichijo, K. Miyazono & M. Kawabata: Induction of Smad6 mRNA by bone morphogenetic proteins. Biochem Biophys Res Commun 244, 26-29 (1998)
13. Itoh S., M. Landstrom, A. Hermansson, F. Itoh, C.H. Heldin, N.E. Heldin & P. ten Dijke: Transforming growth factor β1 induces nuclear export of inhibitory Smad7. J Biol Chem 273, 29195-29201 (1998)
14. Bai S., X. Shi, X. Yang & X. Cao: Smad6 as a transcriptional corepressor. J Biol Chem 275, 8267-8270 (2000)
15. Shi Y., Y.F. Wang, L. Jayaraman, H. Yang, J. Massague & N.P. Pavletich: Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-β signaling. Cell 94, 585-594 (1998)
16. Jonk L.J., S. Itoh, C.H. Heldin, P. ten Dijke & W. Kruijer: Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273, 21145-21152 (1998)
17. Hua X., Z.A. Miller, G. Wu, Y. Shi & H.F. Lodish: Specificity in transforming growth factor β-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins. Proc Natl Acad Sci U S A 96, 13130-13135 (1999)
18. Lindemann R.K., P. Ballschmieter, A. Nordheim & J. Dittmer: Transforming growth factor β regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism. J Biol Chem 276, 46661-46670 (2001)
19. Labbe E., C. Silvestri, P.A. Hoodless, J.L. Wrana & L. Attisano: Smad2 and Smad3 positively and negatively regulate TGF β-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell 2, 109-120 (1998)
20. Chen X., M.J. Rubock & M. Whitman: A transcriptional partner for MAD proteins in TGF-β signalling. Nature 383, 691-696 (1996)
21. Liu B., CL. Dou, L. Prabhu & E. Lai: FAST-2 is a mammalian winged-helix protein which mediates transforming growth factor-β signals. Mol Cell Biol 19, 424-430 (1999)
22. Zhou S., P. Buckhaults, L. Zawel, F. Bunz, G. Riggins, J.L. Dai, S.E. Kern, K.W. Kinzler & B. Vogelstein: Targeted deletion of Smad4 shows it is required for transforming growth factor-β and activin signaling in colorectal cancer cells. Proc Natl Acad Sci USA 95, 2412-2416 (1998)
23. Hata A., J. Seoane, G. Lagna, E. Montalvo, A. Hemmati-Brivanlou & J. Massague: OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100, 229-240 (2000)
24. Liberati N.T., M.B. Datto, J.P. Frederick, X. Shen, C. Wong, E.M. Rougier-Chaprnan & X.F. Wang: Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci USA 96, 4844-4849 (1999)
25. Sano Y., J. Harada, S. Tashiro, R. Gotoh-Mandeville, T. Maekawa & S. Ishii: ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J Biol Chem 274, 8949-8957 (1999)
26. Zhang Y., X.H. Feng & R. Derynck: Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394, 909-913 (1998)
27. Wong C., E.M. Rougier-Chapman, J.P. Frederick, M.B. Datto, N.T. Liberati, J.M. Li & X.F. Wang: Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor -β. Mol Cell Biol 19, 1821-1830 (1999)
28. Hua X., X. Liu, D.O. Ansari & H.F. Lodish: Synergistic cooperation of TFE3 and smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev 12, 3084-3095 (1998)
29. Hua X., Z.A. Miller, H. Benchabane, J.L. Wrana & H.F. Lodish: Synergism between transcription factors TFE3 and Smad3 in transforming growth factor-β-induced transcription of the Smad7 gene. J Biol Chem 275, 33205-33208 (2000)
30. Hanai J., L.F. Chen, T. Kanno, N. Ohtani-Fujita, W.Y. Kim, W.H. Guo, T. Imamura, Y. Ishidou, M. Fukuchi, M.J. Shi, J. Stavnezer, M. Kawabata, K. Miyazono & Y. Ito: Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Cα promoter. J Biol Chem 274, 31577-31582 (1999)
31. Zhang Y. & R. Derynck: Transcriptional regulation of the transforming growth factor-β -inducible mouse germ line Ig α constant region gene by functional cooperation of Smad, CREB, and AML family members. J Biol Chem 275, 16979-16985 (2000)
32. Zhang Y.W., N. Yasui, K. Ito, G. Huang, M. Fujii, J. Hanai, H. Nogami, T. Ochi, K. Miyazono & Y. Ito: A RUNX2/PEBP2α A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A 97, 10549-10554 (2000)
33. Nishimura R., K. Hata, S. Harris, F. Ikeda & T. Yoneda: Core-binding factor α1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 31, 303-312 (2002)
34. Verschueren K., J.E. Remade, C. Collart, H. Kraft, B.S. Baker, P. Tylzanowski, L. Nelles, G. Wuytens, M.T. Su, R. Bodmer, J.C. Smith & D. Huylebroeck: SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5′-CACCT sequences in candidate target genes. J Biol Chem 274, 20489-20498 (1999)
35. Remade J.E., H. Kraft, W. Lerchner, G. Wuytens, C. Collart, K. Verschueren, J.C. Smith & D. Huylebroeck: New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J 18, 5073-5084 (1999)
36. Feng X.H., Y. Zhang, R.Y. Wu & R. Derynck: The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-β-induced transcriptional activation. Genes Dev 12, 2153-2163 (1998)
37. Janknecht R., N.J. Wells & T. Hunter: TGF-β-stimulated cooperation of smad proteins with the coactivators CBP/p300. Genes Dev 12, 2114-2119 (1998)
38. Nakashima K., M. Yanagisawa, H. Arakawa, N. Kimura, T. Hisatsune, M. Kawabata, K. Miyazono & T. Taga: Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 284, 479-482 (1999)
39. Shioda T., R.J. Lechleider, S.L. Dunwoodie, H. Li, T. Yahata, M.P. de Caestecker, M.H. Fenner, A.B. Roberts & K.J. Isselbacher: Transcriptional activating activity of Stnad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. Proc Natl Acad Sci USA 95, 9785-9790 (1998)
40. Yahata T., M.P. de Caestecker, R.J. Lechleider, S. Andriole, A.B. Roberts, K.J. Isselbacher & T. Shioda: The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors. J Biol Chem 275, 8825-8834 (2000)
41. Liu F., A. Hata, J.C. Baker, J. Doody, J. Carcamo, R.M. Harland & J. Massague: A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620-623 (1996)
42. Kim J., K. Johnson, H.J. Chen, S. Carroll & A. Laughon: Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388, 304-308 (1997)
43. Wotton D., R.S. Lo, S. Lee & J. Massague: A Smad transcriptional corepressor. Cell 97, 29-39 (1999)
44. Wotton D., R.S. Lo, L.A. Swaby & J. Massague: Multiple modes of repression by the Smad transcriptional corepressor TGIF. J Biol Chem 274, 37105-37110 (1999)
45. Wotton D., P.S. Knoepfler, C.D. Laherty, R.N. Eisenman & J. Massague: The Smad transcriptional corepressor TGIF recruits mSin3. Cell Growth Differ 12, 457-463 (2001)
46. Luo K., S.L. Stroschein, W. Wang, D. Chen, E. Martens, S. Zhou & Q. Zhou: The Ski oncoprotein interacts with the Smad proteins to repress TGF-β signaling. Genes Dev 13, 2196-2206 (1999)
47. Stroschein S.L., W. Wang, S. Zhou, Q. Zhou & K. Luo: Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 286, 771-774 (1999)
48. Akiyoshi S., H. Inoue, J. Hanai, K. Kusanagi, N. Nemoto, K. Miyazono & M. Kawabata: c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with smads. J Biol Chem 274, 35269-35277 (1999)
49. Liu X., Y. Sun, R.A. Weinberg & H.F. Lodish: Ski/Sno and TGF-β signaling. Cytokine Growth Factor Rev 12, 1-8 (2001)
50. Xu W., K. Angelis, D. Danielpour, M.M. Haddad, O. Bischof, J. Campisi, E. Stavnezer & E.E. Medrano: Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type β transforming growth factor. Proc Natl Acad Sci USA 91, 5924-5929 (2000)
51. Sun Y., X. Liu, E. Ng-Eaton, H.F. Lodish & R.A. Weinberg: SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling. Proc Natl Acad Sci U S A 96, 12442-12447 (1999)
52. Reed J.A., E. Bales, W. Xu, N.A. Okan, D. Bandyopadhyay & E.E. Medrano: Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor β signaling. Cancer Res 61, 8074-8078 (2001)
53. Kurokawa M., K. Mitani, K. Irie, T. Matsuyama, T. Takahashi, S. Chiba, Y. Yazaki, K. Matsumoto & H. Hirai: The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3. Nature 394, 92-96 (1998)
54. Izutsu K., M. Kurokawa, Y. Imai, K. Maki, K. Mitani & H. Hirai: The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling. Blood 97, 2815-2822 (2001)
55. Yanagisawa J., Y. Yanagi, Y. Masuhiro, M. Suzawa, M. Watanabe, K. Kashiwagi, T. Toriyabe, M. Kawabata, K. Miyazono & S. Kato: Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283, 1317-1321 (1999)
56. Labbe E., A. Letamendia & L. Attisano: Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and wnt pathways. Proc Natl Acad Sci U S A 97, 8358-8363 (2000)
57. Crease D.J., S. Dyson & J.B. Gurdon: Cooperation between the activin and Wnt pathways in the spatial control of organizer gene expression. Proc Natl Acad Sci U S A 95, 4398-4403 (1998)
58. Nishita M., M.K. Hashimoto, S. Ogata, M.N. Laurent, N. Ueno, H. Shibuya & K.W. Cho: Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer. Nature 403, 781-785 (2000)
59. Ulloa L., J. Doody & J. Massague: Inhibition of transforming growth factor-β/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397, 710-713 (1999)
60. Kretzschmar M., J. Doody & J. Massague: Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389, 618-622 (1997)
61. Kretzschmar M., J. Doody, I. Timokhina & J. Massague: A mechanism of repression of TGF-β/ Smad signaling by oncogenic Ras. Genes Dev 13, 804-816 (1999)
62. de Caestecker M.P., W.T. Parks, C.J. Frank, P. Castagnino, D.P. Bottaro, A.B. Roberts & R.J. Lechleider: Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev 12, 1587-1592 (1998)
63. Zhu H., P. Kavsak, S. Abdollah, J.L. Wrana & G.H. Thomsen: A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687-693 (1999)
64. Hanyu A., Y. Ishidou, T. Ebisawa, T. Shimanuki, T. Imamura & K. Miyazono: The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling. J Cell Biol 155, 1017-1027 (2001)
65. Bonni S., H.R. Wang, C.G. Causing, P. Kavsak, S.L. Stroschein, K. Luo & J.L. Wrana: TGF-β induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol 3, 587-595 (2001)
66. Kavsak P., R.K. Rasmussen, C.G. Causing, S. Bonni, H. Zhu, G.H. Thomsen & J.L. Wrana: Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF β receptor for degradation. Mol Cell 6, 1365-1375 (2000)
67. Ebisawa T., M. Fukuchi, G. Murakami, T. Chiba, K. Tanaka, T. Imamura & K. Miyazono: Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276, 12477-12480 (2001)
68. Fukuchi M., T. Imamura, T. Chiba, T. Ebisawa, M. Kawabata, K. Tanaka & K. Miyazono: Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell 12, 1431-1443 (2001)
69. Xu J. & L. Attisano: Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor β signaling by targeting Smads to the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 91, 4820-4825 (2000)
70. Yamaguchi A., T. Komori & T. Suda: Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21, 393-411 (2000)
71. Reddi A.H.: Bone and cartilage differentiation. Curr Opin Genet Dev 4, 737-744 (1994)
72. Nishimura R., Y. Kato, D. Chen, S.E. Harris, G.R. Mundy & T. Yoneda: Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 273, 1872-1879 (1998)
73. Fujii M., K. Takeda, T. Imamura, H. Aoki, T.K. Sampath, S. Enomoto, M. Kawabata, M. Kato, H. Ichijo & K. Miyazono: Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell, 10, 3801-3813 (1999)
74. Yamamoto N., S. Akiyama, T. Katagiri, M. Namiki, T. Kurokawa & T. Suda: Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 238, 574-580 (1997)
75. Mundlos S., F. Otto, C. Mundlos, J.B. Mulliken, A.S. Aylsworth, S. Albright, D. Lindhout, W.G. Cole, W. Henn, J.H. Knoll, M.J. Owen, R. Mertelsmann, B.U. Zabel & B.R. Olsen: Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779 (1997)
76. Komori T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R.T. Bronson, Y.H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki & T. Kishimoto: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764 (1997)
77. Otto F., A.P. Thornell, T. Crompton, A. Denzel, K.C. Gilmour, I.R. Rosewell, G.W. Stamp, R.S. Beddington, S. Mundlos, B.R. Olsen, P.B. Selby & M.J. Owen: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771 (1997)
78. Ducy P., R. Zhang, V. Geoffroy, A.L. Ridall & G. Karsenty: Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754 (1997)
79. Harada H., S. Tagashira, M. Fujiwara, S. Ogawa, T. Katsumata, A. Yamaguchi, T. Komori & M. Nakatsuka: Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274, 6972-6978 (1999)
80. Lee K.S., H.J. Kim, Q.L. Li, X.Z. Chi, C. Ueta, T. Komori, J.M. Wozney, E.G. Kim, J.Y. Choi, H.M. Ryoo & S.C. Bae: Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20, 8783-8792 (2000)
81. Yoshida Y., S. Tanaka, H. Umemori, O. Minowa, M. Usui, N. Ikematsu, E. Hosoda, T. Imamura, J. Kuno, T. Yamashita, K. Miyazono, M. Noda, T. Noda & T. Yamamoto: Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103, 1085-1097 (2000)
82. Reimold A.M., M.J. Grusby, B. Kosaras, J.W. Fries, R. Mori, S. Maniwa, I.M. Clauss, T. Collins, R.L. Sidman, M.J. Glimcher & L.H. Glimcher: Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 379, 262-265 (1996)